Stocks · News reference
Novo Nordisk announced that the US FDA has approved Awiqli® (insulin icodec-abae) as a once-weekly basal insulin for children aged 10 and older with type 2 diabetes.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Novo Nordisk announced it will present 12 new abstracts featuring real-world and clinical data on semaglutide at the American Association for the Study of Liver Diseases (AASLD) congress in November 2026.
Copenhagen Airports A/S has appointed Sofie Mørck Jarl as its new CFO, effective no later than 1 March 2027. Jarl joins from Novo where she served as Group Vice President for Finance & Business Support, and previously worked as CFO at Novo Nordisk Engineering A/S. She succeeds Rasmus Lund, who passed away in July. The CEO praised her extensive financial and strategic expertise, particularly her experience managing major investments and complex projects.
Copenhagen Airports A/S has appointed Sofie Mørck Jarl as its new CFO, effective March 1, 2027. She joins from Novo Nordisk where she served as Group Vice President for Finance & Business Support, bringing experience in financial leadership, strategy, and major investment management. She replaces Rasmus Lund, who passed away unexpectedly in July.